3 Things In Biotech You Should Learn Today: June 27, 2017 – Seeking Alpha
|
3 Things In Biotech You Should Learn Today: June 27, 2017
Seeking Alpha Novartis (NYSE:NVS) has been one of the driving forces in the study of T cells expressing chimeric antigen receptors (CARs) directed at CD19 on B cells, a technique known as CAR–T cell therapy. Its product, CTL019, has already been shown to help a … |
